Granules India G N Prashanth resigns as Senior Vice President - Corporate Quality

Written by Ruchika Sharma Published On 2025-04-19T16:21:45+05:30 | Updated On 19 April 2025 4:21 PM IST

Granules India G N Prashanth resigns as Senior Vice President - Corporate Quality

Granules India has announced the resignation of G. N. Prashanth from the position of Senior Vice President - Corporate Quality of the Company due to personal reasons.

"G. N. Prashanth, shall cease to be the Senior Management Personnel (SMP) of the Company upon his resignation from the position of Senior Vice President- Corporate Quality with effect from the closure of business hours of April 18, 2025," Granules India stated in a BSE filing.

G. N. Prashanth is a postgraduate in pharmacy from Bangalore University and holds a graduate certification from IIMB. He has more than 30 years of experience and has worked in companies like Cipla, AstraZeneca, Orchid Chemicals and Pharmaceuticals, Neopharma, Kemwell, Microlabs, and Strides. He has experience in various functions like Quality Control, Analytical Development, Quality Assurance, Regulatory Affairs, and Project Management. He joined Granules in Oct 2019 as Senior Vice President and Head of Corporate Quality.

Granules India Limited, incorporated in 1991 is a vertically integrated Indian pharmaceutical company headquartered in Hyderabad. Amongst the few pharmaceutical companies in the world to be present across the manufacturing of the entire pharmaceutical value chain – from Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs), and Finished Dosages (FDs), Granules products are distributed to over 300+ customers in regulated and semiregulated markets with a global presence extending to over 80+ countries with offices across India, US and UK. The Company has 10 manufacturing facilities out of which 8 are located in India and 2 are in the USA and has regulatory approvals from the US FDA, EDQM, EU GMP, COFEPRIS, WHO GMP, TGA, K FDA, DEA, MCC, and HALAL.

granule indiagranules india newsG N Prashanthresignation

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751